Partnership Forum: Participants examined how to improve decision making for prior authorization and step therapy based on current market dynamics and considerations to ensure patients receive the most appropriate medications.

Where We Stand: AMCP supports the use of evidence‐based formularies that enhance the quality of pharmaceutical care while lowering medication costs

Where We Stand: AMCP encourages the use of generic drugs as safe, cost- effective alternatives to the equivalent brand-name products

Where We Stand: AMCP supports off‐label use of FDA‐approved drugs when medically appropriate and necessary, but opposes government‐mandated coverage of specific pharmaceuticals, whether for FDA‐approved or off‐label uses. 

Where We Stand: Appropriate access to and use of prescription medications promotes both patient well‐being and the efficient use of medical resources.

Where We Stand: AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.

AMCP webinar that reviewed the current pre-approval support features within FormuarlyDecisions.com and insights from the active FormularyDecisions.com Payer community.